Global Blood Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GBT and buy or sell other stocks, ETFs, and their options commission-free!About GBT
GBT is a clinical-stage biopharmaceutical company that focuses on discovering, developing, and delivering innovative treatments that provide hope to underserved patient communities. GBT is developing its product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease.
CEOBert Bruce
CEOBert Bruce
Employees—
Employees—
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2011
Founded2011
Employees—
Employees—
GBT Key Statistics
Market cap4.62B
Market cap4.62B
Price-Earnings ratio-13.70
Price-Earnings ratio-13.70
Dividend yield—
Dividend yield—
Average volume2.06M
Average volume2.06M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$73.02
52 Week high$73.02
52 Week low$21.65
52 Week low$21.65